首页 | 本学科首页   官方微博 | 高级检索  
     


Injectable Ovalbumin-Based Composite Implant for Photothermal Tumor Therapy
Authors:Jing Zhang  Dr. Xiao An  Yuting Zheng  Yongkang Chen  Chenyao Wu  Dr. Shige Wang
Affiliation:1. College of Science, University of Shanghai for Science and Technology, No. 334 Jungong Road, Shanghai, 200093 P. R. China

These authors contributed equally to this work.;2. Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100 Haining Road, Shanghai, 200080 P. R. China

These authors contributed equally to this work.;3. College of Science, University of Shanghai for Science and Technology, No. 334 Jungong Road, Shanghai, 200093 P. R. China

Abstract:Polymeric hydrogels with three-dimensional network structures have found tremendous applications in biomedicine. Herein, we report the synthesis of a multifunctional implant based on ovalbumin (OVA) as a carrier capable of synergistically delivering a photothermal transducing agent (polydopamine, PDA) to tumors. The formation of PDA was achieved by utilizing the basicity of OVA, whereas the formation of the hydrogel implant was achieved through the in vitro/in vivo near-infrared (NIR) laser-induced hyperthermia of PDA. The as-prepared PDA@OVA implant exhibits high photothermal conversion efficiency (38.7 %). Once implanted in vivo, the OVA-based implant shows great versatility in the treatment of malignant tumors. Furthermore, a chemotherapeutic (doxorubicin, DOX) and a contrast agent (iohexol), dispersed in the OVA solution in advance, can also be firmly entrapped in the hydrogel along with the hydrogel formation. It is anticipated that the multifunctional OVA-based implant, not showing any obvious toxicity to healthy tissue, could be a promising system for synergistic cancer treatment.
Keywords:cancer  drug delivery  hyperthermia  imaging agents  polydopamine
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号